Morgan Stanley’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Buy
81,733
+38,633
+90% +$483K ﹤0.01% 5089
2025
Q1
$750K Buy
43,100
+14,538
+51% +$253K ﹤0.01% 5139
2024
Q4
$1.09M Buy
28,562
+5,207
+22% +$198K ﹤0.01% 5043
2024
Q3
$781K Buy
23,355
+10,334
+79% +$345K ﹤0.01% 5181
2024
Q2
$441K Buy
13,021
+5,352
+70% +$181K ﹤0.01% 5346
2024
Q1
$690K Sell
7,669
-4,267
-36% -$384K ﹤0.01% 5161
2023
Q4
$572K Buy
11,936
+11,232
+1,595% +$538K ﹤0.01% 5564
2023
Q3
$13K Buy
704
+620
+738% +$11.5K ﹤0.01% 6632
2023
Q2
$1.46K Sell
84
-1,648
-95% -$28.6K ﹤0.01% 7241
2023
Q1
$43.6K Buy
1,732
+1,280
+283% +$32.2K ﹤0.01% 6333
2022
Q4
$87K Sell
452
-148
-25% -$28.5K ﹤0.01% 6047
2022
Q3
$54K Sell
600
-718
-54% -$64.6K ﹤0.01% 6372
2022
Q2
$99K Buy
1,318
+279
+27% +$21K ﹤0.01% 6281
2022
Q1
$110K Sell
1,039
-2,969
-74% -$314K ﹤0.01% 6247
2021
Q4
$1.03M Sell
4,008
-6,568
-62% -$1.69M ﹤0.01% 5048
2021
Q3
$3.73M Sell
10,576
-3,710
-26% -$1.31M ﹤0.01% 4025
2021
Q2
$7.12M Buy
14,286
+14,015
+5,172% +$6.98M ﹤0.01% 3395
2021
Q1
$129K Sell
271
-7,796
-97% -$3.71M ﹤0.01% 5881
2020
Q4
$14.2M Buy
8,067
+7,834
+3,362% +$13.8M ﹤0.01% 2157
2020
Q3
$225K Sell
233
-1,380
-86% -$1.33M ﹤0.01% 5044
2020
Q2
$1.88M Buy
1,613
+1,516
+1,563% +$1.76M ﹤0.01% 3658
2020
Q1
$86K Sell
97
-168
-63% -$149K ﹤0.01% 5244
2019
Q4
$232K Buy
+265
New +$232K ﹤0.01% 5355